202 studies found for:    Open Studies | "Influenza, Human"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Conditions: Influenza, Human;   Flu, Human;   Flu, Avian;   Influenza;   Influenza A Virus, H5N1 Subtype
Interventions: Biological: Novartis Investigational H5N1 vaccine;   Biological: Novartis Seasonal Influenza Vaccine
2 Recruiting INSIGHT Influenza Hospitalization Study (FLU 003)
Conditions: Influenza;   (Influenza A and Subtypes Such as H3N2 and 2009 H1N1 or Influenza B)
Intervention:
3 Unknown  The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients
Conditions: Influenza A;   Swine Flu
Interventions: Dietary Supplement: Pomegranate juice;   Dietary Supplement: Placebo drink
4 Recruiting Detection of Influenza A, Influenza B, and RSV Using the Liat Analyzer
Conditions: Influenza A;   Influenza B;   RSV
Intervention:
5 Unknown  Seasonal Influenza Vaccine Effectiveness Study in Kenya
Conditions: Influenza;   Influenza Like Illness;   Severe Acute Respiratory Illness
Intervention: Biological: Seasonal influenza vaccine
6 Recruiting e- Ab Sensor - Based Real-time Diagnosis of Influenza Virus
Condition: Influenza Caused by Unspecified Influenza Virus
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
7 Recruiting A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza
Condition: Influenza, Human
Interventions: Drug: 300mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 600mg intravenous (IV) zanamivir and oral oseltamivir placebo;   Drug: 75mg oral oseltamivir and intravenous zanamivir placebo
8 Recruiting A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
Conditions: Influenza;   Flu
Intervention: Drug: Anti-influenza IVIG
9 Recruiting Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital
Condition: Influenza, Human
Intervention: Drug: zanamivir aqueous solution
10 Not yet recruiting A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).
Condition: Live Attenuated Influenza Vaccine
Intervention: Drug: Fluenz
11 Recruiting A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.
Condition: Influenza, Human
Interventions: Biological: Quadrivalent Influenza Vaccine (QIV);   Biological: Trivalent Influenza Vaccine (TIV-1);   Biological: Trivalent Influenza Vaccine (TIV-2)
12 Recruiting Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Conditions: Influenza, Human;   Smoking;   Respiratory Tract Infections;   Habits
Intervention: Biological: LAIV
13 Recruiting Influenza in People With Normal and Weakened Immune Systems
Conditions: Influenza, Human;   Immunocompromised Host
Intervention:
14 Recruiting Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China
Conditions: Influenza Type A;   Influenza Type B
Intervention: Other: Nasopharyngeal Swab
15 Recruiting Screening Volunteers for Influenza Challenge Studies
Condition: Influenza, Human
Intervention:
16 Recruiting Treatment of Severe Influenza A Infection
Condition: Influenza, Human
Interventions: Drug: Celecoxib;   Drug: Oseltamivir;   Drug: Placebo
17 Recruiting Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza
Condition: Influenza
Interventions: Biological: TCN-032;   Biological: Placebo (saline)
18 Recruiting Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
Condition: Influenza, Human
Interventions: Drug: Intanza;   Drug: Vaxigrip
19 Recruiting Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Condition: Influenza, Human
Interventions: Drug: Oseltamivir;   Drug: Oseltamivir Placebo
20 Recruiting Evaluate Reactogenicity and Immunogenicity of Standard-dose (SD) Versus High-dose (HD) Inactivated Influenza Vaccine Trivalent (IIV3) in Recipients of Solid Organ Transplants.
Conditions: Influenza, Human;   Transplantation Infection
Interventions: Biological: influenza trivalent inactive vaccine;   Biological: influenza trivalent inactive vaccine high dose

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years